- Home
- PROK vs AMPY Comparison
PROK vs AMPY Comparison
Compare PROK & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PROK | AMPY |
|---|---|---|
| Founded | 2015 | 2011 |
| Country | United States | United States |
| Employees | 231 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 269.7M | 246.9M |
| IPO Year | 2021 | 2011 |
Fundamental Metrics
Financial Performance| Metric | PROK | AMPY |
|---|---|---|
| Price | $1.81 | $6.19 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $7.40 | N/A |
| AVG Volume (30 Days) | 795.9K | ★ 1.4M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 232.26 |
| EPS | N/A | ★ 1.03 |
| Revenue | $893,000.00 | ★ $208,637,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $25.00 | $14.60 |
| P/E Ratio | ★ N/A | $5.81 |
| Revenue Growth | ★ 1075.00 | N/A |
| 52 Week Low | $0.46 | $2.27 |
| 52 Week High | $7.13 | $6.79 |
Technical Indicators
Market Signals| Indicator | PROK | AMPY |
|---|---|---|
| Relative Strength Index (RSI) | 43.61 | 52.95 |
| Support Level | $1.71 | $5.04 |
| Resistance Level | $2.58 | $6.71 |
| Average True Range (ATR) | 0.14 | 0.32 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 42.97 | 38.92 |
Price Performance
Historical ComparisonAbout PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company pioneering the development of a first-in-class, autologous cell therapy that is intended to preserve kidney function in patients with advance chronic kidney disease (CKD) and diabetes. Its product candidate, REACT (Renal Autologous Cell Therapy), is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.
About AMPY Amplify Energy Corp.
Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.